Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Cell

• Publication date

  2015-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2015.02.014PMID 25843002PMCID PMC6591140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Getting TRAIL back on track for cancer therapy

  2014cited by this paper
• The Rac-FRET Mouse Reveals Tight Spatiotemporal Control of Rac Activity in Primary Cells and Tissues

  2014cited by this paper
• Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.

  2014cited by this paper
• RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms

  2013cited by this paper
• Surgical implantation of an abdominal imaging window for intravital microscopy

  2013cited by this paper
• Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

  2013cited by this paper
• K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

  2013cited by this paper
• Rac function is crucial for cell migration but is not required for spreading and focal adhesion formation

  2013cited by this paper
• ROS Production and NF-κB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation

  2013cited by this paper
• Kinome profiling of non-canonical TRAIL signaling reveals RIP1–Src–STAT3-dependent invasion in resistant non-small cell lung cancer cells

  2012cited by this paper
• miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

  2012cited by this paper
• KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

  2012cited by this paper
• β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity

  2012cited by this paper
• Inhibition of Ras for cancer treatment: the search continues.

  2011cited by this paper
• Early requirement of Rac1 in a mouse model of pancreatic cancer.

  2011cited by this paper
• TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5

  2010cited by this paper
• Mad2-induced chromosome instability leads to lung tumor relapse after oncogene withdrawal

  2010cited by this paper
• Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

  2010cited by this paper
• Biosensors for Characterizing the Dynamics of Rho Family GTPases in Living Cells

  2010cited by this paper
• Abstract 1260: Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

  2010cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• The plasticity of cytoskeletal dynamics underlying neoplastic cell migration.

  2010cited by this paper
• Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.

  2010influential reference
• Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer

  2009influential reference
• Visualization of small GTPase activity with fluorescence resonance energy transfer-based biosensors

  2009cited by this paper
• Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer

  2009cited by this paper
• TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis.

  2008cited by this paper
• Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.

  2008influential reference
• Targeting RAS and PI3K in lung cancer

  2008cited by this paper
• Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4

  2008cited by this paper
• TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.

  2008cited by this paper
• Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers

  2008cited by this paper
• Rac activation and inactivation control plasticity of tumor cell movement.

  2008cited by this paper
• TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

  2008cited by this paper
• Mammalian Rho GTPases: new insights into their functions from in vivo studies

  2008cited by this paper
• Bortezomib Sensitizes Primary Human Astrocytoma Cells of WHO Grades I to IV for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

  2007cited by this paper
• Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.

  2007cited by this paper
• Differential expression of TRAIL and its receptors in benign and malignant prostate tissues.

  2007cited by this paper
• Requirement for Rac1 in a K-ras induced lung cancer in the mouse.

  2007influential reference
• TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma

  2006cited by this paper
• Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells.

  2006cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand*

  2005influential reference
• Expression of TRAIL and TRAIL receptors in normal and malignant tissues

  2005cited by this paper
• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

  2003cited by this paper
• TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB

  2003cited by this paper
• Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

  2003cited by this paper
• Cytogenetics and molecular genetics of lung cancer.

  2002cited by this paper
• Activation of Rac and Cdc42 Video Imaged by Fluorescent Resonance Energy Transfer-Based Single-Molecule Probes in the Membrane of Living Cells

  2002cited by this paper
• Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism

  2002influential reference
• Focus on pancreas cancer.

  2002influential reference
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1

  2002cited by this paper
• Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8

  2002cited by this paper
• Genetic and epigenetic alterations in colon cancer.

  2002cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001cited by this paper
• Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical Caspases*

  2001cited by this paper
• Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8*

  2001cited by this paper
• Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.

  2001influential reference
• Localized Rac activation dynamics visualized in living cells.

  2000cited by this paper
• Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

  2000cited by this paper
• FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.

  2000cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

  1999influential reference
• Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos.

  1998cited by this paper
• The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

  1997cited by this paper
• Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

  1993influential reference
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas

  1984cited by this paper

• The interplay between circadian rhythm components and apoptosis in health and disease

  2026cites this paper
• Molecular subtyping and immune microenvironment heterogeneity in pediatric influenza-associated prolonged multiple organ dysfunction syndrome

  2026cites this paper
• Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma

  2025cites this paper
• Assessing causal associations between TNF-related apoptosis-inducing ligand, vascular endothelial growth factor and colon cancer: a Mendelian-randomization study

  2025cites this paper
• TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells.

  2025cites this paper
• Bioorthogonal click chemistry-mediated conjugation of an anti-DR4 antibody to gold nanorods enhances its pro-apoptotic activity under near infra-red-light stimulation

  2025cites this paper
• Death ligand receptor (DLR) signaling: Its non-apoptotic functions in cancer and the consequences of DLR-directed therapies.

  2025cites this paper
• Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cells

  2024influential citation
• Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome

  2024cites this paper
• Low level of tumor necrosis factor α in tumor microenvironment maintains self-renewal of glioma stem cells by Vasorin-mediated glycolysis.

  2024cites this paper
• TRIAL-based combination therapies in cancers.

  2024cites this paper
• Microplastics have additive effects on cadmium accumulation and toxicity in Rice flower carp (Procypris merus).

  2024cites this paper
• TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling

  2024influential citation
• A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer

  2024cites this paper
• TRAIL-induced apoptosis and proteasomal activity - Mechanisms, signalling and interplay.

  2024cites this paper
• Effects of electric fields on the release and content of extracellular vesicles

  2024cites this paper
• Immunomodulatory Functions of TNF-Related Apoptosis-Inducing Ligand in Type 1 Diabetes

  2024cites this paper
• Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer

  2024cites this paper
• Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding

  2023cites this paper
• Death receptor 5 promotes tumor progression in gastric cancer

  2023cites this paper
• Noncanonical TRAIL Signaling Facilitates Tumor Immunosuppression and Cholangiocarcinoma Growth via Myeloid-Derived Suppressor Cells

  2023cites this paper
• BTB protein family and human breast cancer: signaling pathways and clinical progress

  2023cites this paper
• It is the Frequency that Matters

  2023cites this paper
• Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma

  2023cites this paper
• The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis

  2023cites this paper
• Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

  2022cites this paper
• TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma

  2022influential citation
• Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation

  2022cites this paper
• Extrinsic cell death pathway plasticity: a driver of clonal evolution in cancer?

  2022cites this paper
• Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy

  2022cites this paper
• When cell death goes wrong: inflammatory outcomes of failed apoptosis and mitotic cell death

  2022cites this paper
• Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries

  2022influential citation
• Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells

  2022cites this paper
• Role of TRAIL-R in Primary and Secondary Genital and Respiratory Chlamydia muridarum Infections in Mice

  2022cites this paper
• Nanodiamonds Improve Arsenic Trioxide Treatment of Liver Tumor by Inhibiting Metastasis in Multiple Organs

  2022cites this paper
• KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer

  2022cites this paper
• Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells

  2022cites this paper
• [6. Imaging Biopsy for Assisting Cancer Precision Therapy -Information Extracted from Radiomics].

  2022cites this paper
• Astaxanthin Sensitizes Low SOD2-Expressing GBM Cell Lines to TRAIL Treatment via Pathway Involving Mitochondrial Membrane Depolarization

  2022cites this paper
• Advances in the Relationship Between Regulator of Ribosome Synthesis 1 (RRS1) and Diseases

  2021cites this paper
• Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers

  2021cites this paper
• De novo assembly and transcriptome characterization: Novel insights into the mechanisms of primary ovarian cancer in Microtus fortis

  2021cites this paper
• How open is the therapeutic horizon for pancreatic cancer patients?

  2021cites this paper
• TRAIL-receptor 2—a novel negative regulator of p53

  2021cites this paper
• The synthesis and bioactivity of pyrrolo[2,3-d]pyrimidine derivatives as tyrosine kinase inhibitors for NSCLC cells with EGFR mutations.

  2021cites this paper
• LncRNA AC079630.4 expression associated with the progression and prognosis in lung cancer

  2021cites this paper
• Twist1 contributes to developing and sustaining corticosteroid resistance in ulcerative colitis

  2021cites this paper
• Modes of Regulated Cell Death in Cancer.

  2021cites this paper
• The Program Cell Death (Apoptosis) and the Therapy of Cancer

  2021cites this paper
• From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis

  2021cites this paper
• Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins

  2021cites this paper
• Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling

  2021influential citation
• Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis

  2021cites this paper
• Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification

  2021influential citation
• Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p

  2021cites this paper
• Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage

  2021cites this paper
• Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors

  2021cites this paper
• Targeting apoptosis in cancer therapy

  2020cites this paper
• An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer

  2020cites this paper
• Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR‐296‐5p/Bax axis

  2020cites this paper
• Dasatinib prevents skeletal metastasis of osteotropic MDA-MB-231 cells in a xenograft mouse model

  2020cites this paper
• Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis

  2020cites this paper
• Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation

  2020cites this paper
• Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism

  2020cites this paper
• Chapter 2 TRAIL-R 3 / R 4 and Inhibition of TRAIL Signalling in Cancer

  2020cites this paper
• Death Receptors and Their Ligands in Inflammatory Disease and Cancer.

  2020cites this paper
• TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas

  2020cites this paper
• The multifaceted role of TRAIL signaling in cancer and immunity

  2020cites this paper
• The Problem of Apoptotic Processes Reversibility

  2020cites this paper
• Rose (Rosa gallica) Petal Extract Suppress Proliferation, Migration, and Invasion of Human Lung Adenocarcinoma A549 Cells through via the EGFR Signaling Pathway

  2020cites this paper
• TRAIL of Hope Meeting Resistance in Cancer.

  2020cites this paper
• TRAIL mediated signaling as a double-edged sword in pancreatic cancer: Analysis of brighter and darker sides of the pathway.

  2020cites this paper
• DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models.

  2020cites this paper
• Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer

  2020cites this paper
• Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids

  2020cites this paper
• A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells

  2020cites this paper
• Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer

  2020cites this paper
• TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response.

  2020cites this paper
• ER Stress Leaves an Inflammatory TRAIL.

  2020cites this paper
• Ligand nanovectorization using graphene to target cellular death receptors of cancer cell

  2019influential citation
• The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics.

  2019cites this paper
• T Cells and Regulated Cell Death: Kill or Be Killed.

  2019cites this paper
• RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer

  2019cites this paper
• Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy

  2019cites this paper
• TRAILblazing Strategies for Cancer Treatment

  2019cites this paper
• Regulation of death receptor signaling by the autophagy protein TP53INP2

  2019cites this paper
• DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.

  2019cites this paper
• TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity

  2019cites this paper
• The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway.

  2019cites this paper
• The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection

  2019cites this paper
• Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients

  2019cites this paper
• The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases

  2019cites this paper
• Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation

  2019cites this paper
• TP53INP2 at the crossroad of apoptosis and autophagy in death receptor signaling

  2019cites this paper
• Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox

  2019cites this paper
• Interactions of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) with the Immune System: Implications for Inflammation and Cancer

  2019cites this paper
• TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors

  2019cites this paper
• TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells

  2019cites this paper